Milestone Scientific Inc. (MLSS)

Market Cap	47.14M
Revenue (ttm)	9.08M
Net Income (ttm)	-6.97M
Shares Out	78.56M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,249
Open	0.6090
Previous Close	0.5939
Day's Range	0.5751 - 0.6100
52-Week Range	0.3753 - 1.3930
Beta	0.80
Analysts	Buy
Price Target	1.25 (+108.33%)
Earnings Date	Aug 14, 2025

About MLSS

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery sys...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 3, 1995
• Employees: 17
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: MLSS
• Website: https://www.milestonescientific.com

Financial Performance

In 2024, Milestone Scientific's revenue was $8.63 million, a decrease of -12.19% compared to the previous year's $9.83 million. Losses were -$4.71 million, -31.97% less than in 2023.

Analyst Summary

According to one analyst, the rating for MLSS stock is "Buy" and the 12-month stock price target is $1.25.

Price Target

$1.25

(108.33% upside)

Analyst Consensus: Buy